Kestra Private Wealth Services’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,555
Closed -$247K 898
2022
Q3
$247K Sell
2,555
-1,922
-43% -$229K 0.01% 713
2022
Q2
$471K Sell
4,477
-45
-1% -$5.75K 0.03% 524
2022
Q1
$779K Sell
4,522
-583
-11% -$87.1K 0.04% 442
2021
Q4
$826K Sell
5,105
-1,400
-22% -$225K 0.04% 441
2021
Q3
$970K Buy
+6,505
New +$1.35M 0.05% 357

Other funds holding AMED

Kestra Private Wealth Services's AMED Position: Q4 2022 in Review

Kestra Private Wealth Services sold out of Amedisys (AMED) in Q4 2022, closing a stake of 2,555 shares — an estimated $247K sold.

Kestra Private Wealth Services first reported a position in AMED in Q3 2021 and held it in 5 quarters. The position peaked at $970K in Q3 2021. 277 funds tracked by Wall St. Rank hold AMED as of Q4 2022.

  • Kestra Private Wealth Services reported no remaining Amedisys position as of Q4 2022 after selling out during the quarter.
  • Kestra Private Wealth Services sold 2,555 Amedisys shares in Q4 2022, an estimated $247K.
  • Kestra Private Wealth Services first reported a position in Amedisys in Q3 2021 and held it in 5 quarters.
  • Kestra Private Wealth Services's Amedisys position peaked at $970K in Q3 2021.
  • 277 funds tracked by Wall St. Rank held Amedisys as of Q4 2022.

Based on Kestra Private Wealth Services's 13F filing for Q4 2022, filed 1 Feb 2023.